October 14, 2020
A New York federal judge tossed a proposed class action Wednesday that alleged pharmaceutical research and development company WuXi PharmaTech misled investors by not disclosing a strategy to spin off three subsidiaries.
May 29, 2019
Law firm Pomerantz will serve as lead counsel in a proposed class action accusing pharmaceutical research and development company WuXi of keeping investors in the dark about plans to spin off subsidiaries following a merger that took the company private, a New York federal judge has ruled.
February 22, 2019
A putative class of investors alleged in New York federal court on Thursday that pharmaceutical research and development company WuXi PharmaTech kept them in the dark about plans to spin off subsidiaries following a $3.6 billion merger that took the company private.